African Journal of
Pharmacy and Pharmacology

  • Abbreviation: Afr. J. Pharm. Pharmacol.
  • Language: English
  • ISSN: 1996-0816
  • DOI: 10.5897/AJPP
  • Start Year: 2007
  • Published Articles: 2288

Full Length Research Paper

Expression and clinical significance of matrix metalloproteinase 9 (MMP9) papillary thyroid carcinomas

Xianying Meng1, Tebo Hua1, Qiang Zhang1, Renzhu Pang1, Guibin Zheng1 and Dong Song2*
1Department of Thyroid Surgery, The First Affiliated Hospital of Jilin University, Changchun, Jilin 130021, China. 2Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Jilin University, Changchun, Jilin 130021, China.
Email: [email protected]

  •  Accepted: 23 August 2012
  •  Published: 29 November 2012

Abstract

Matrix metalloproteinases (MMPs) play a crucial role in tumor invasion and metastasis. There have been only a few studies on the MMP expression in thyroid carcinomas. Therefore, we investigated the MMP9 expression in 66 papillary thyroid carcinomas (PTC) using immunohistochemistry and quantitative reverse transcription-polymerase chain reaction (qRT-PCR) on protein level and mRNA level, respectively. We also examined the correlations between the immunohistochemical scores and several clinicopathological parameters. The results demonstrated that MMP9 was significantly up-regulated in cancer tissue in comparison to begnin thyoid tumor tissue on mRNA level (P < 0.05). On protein level, MMP9 was also highly increased in cancer tissue in comparison to begnin thyoid tumor. It is found that high expression MMP9 proteins significantly correlated with large tumor size, presence of lymph node metastasis, Union Internationale Control Cancer (UICC) stage. These data suggest that MMP9 proteins are increased in tumors cells of PTC and that it plays an important role in the invasion and metastasis of PTC.

 

Key words: Thyroid carcinomas, matrix metalloproteinase 9 (MMP9), quantitative reverse transcription-polymerase chain reaction (qRT-PCR), immunohistochemistry, papillary thyroid carcinomas.